Hydrogen sulfide (H 2S) has recently emerged as an important mediator of mammalian cardiovascular homeostasis. In nonmammalian vertebrates, little is known about the cardiac effects of H 2S. This study aimed to evaluate, in the avascular heart of the frog, Rana esculenta, whether and to what extent H 2S affects the cardiac performance, and what is the mechanism of action responsible for the observed effects. Results were analyzed in relation to those obtained in the rat heart, used as the mammalian model. Isolated and perfused (working and Langendorff) hearts, Western blot analysis, and modified biotin switch (S-sulfhydration) assay were used. In the frog heart, NaHS (used as H 2S donor, 10 Ϫ12 /10 Ϫ7 M) dose-dependently decreased inotropism. This effect was reduced by glibenclamide (K ATP channels blocker), 3-a]quinoxalin-1-one (guanylyl cyclase inhibitor), KT 5823 (PKG inhibitor), and it was blocked by Akt1/2 (Akt inhibitor) and by detergent Triton X-100. In the rat, in addition to the classic negative inotropic effect, NaHS (10 Ϫ12 /10 Ϫ7 M) exhibited negative lusitropism. In both frog and rat hearts, NaHS treatment induced Akt and eNOS phosphorylation and an increased cardiac protein S-sulfhydration that, in the rat heart, includes phospholamban. Our data suggest that H 2S represents a phylogenetically conserved cardioactive molecule. Results obtained on the rat heart extend the role of H 2S also to cardiac relaxation. H2S effects involve K ATP channels, the Akt/NOS-cGMP/PKG pathway, and S-sulfhydration of cardiac proteins. hydrogen sulfide; inotropism; lusitropism; nitric oxide synthasecGMP/PKG pathway HYDROGEN SULFIDE (H 2 S), AN endogenous signaling molecule, influences a wide range of physiological and pathological processes. First described as a physiological mediator in the brain (1) and then in the cardiovascular system (24), H 2 S quickly emerged as a cytoprotective molecule with effects on neurotransmission, neuroprotection, insulin release, inflammation, vessel motility, and cardioprotection (51). Along with nitric oxide (NO) and carbon monoxide (CO), it is now recognized as the third endogenous gasotransmitter (20,48,49). In mammals, H 2 S is produced via the cysteine metabolic enzymes cystathionine -synthase (CBS), cystathionine ␥-lyase (CSE) (1, 24), and the combined actions of cysteine aminotransferase and 3-mercaptopyruvate sulfurtransferase (42,43). CBS predominates in the brain, while CSE is the major H 2 S-producing enzyme in the cardiovascular system, where it is present in both vascular smooth muscle and endothelium (24, 52).In all vertebrates, H 2 S was suggested to act as an oxygen sensor, being possibly involved in vascular responses to changes in oxygen availability. During normoxia, cytosolic H 2 S biosynthesis is counteracted by mitochondrial H 2 S oxidation. In contrast, during hypoxia, the low oxygen levels allow vascular H 2 S accumulation, thus modulating the vascular tone (35, 38).The cardiovascular role of H 2 S is well documented in mammals. H 2 S-induced vasodilation of mam...